Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2511582 | Antiviral Research | 2007 | 6 Pages |
Abstract
The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
I.G. Barr, A.C. Hurt, P. Iannello, C. Tomasov, N. Deed, N. Komadina,